Provides telehealth consultations and related medical care to patients, including patients identified by government authorities, and employee healthcare and wellness services to corporate customers.
20-F for FY2025, filed Oct 31, 2025
Patients pay through MaNaDr after teleconsultations; the company also provides consultations under government contracts. Clinics and end customers buy medicines and healthcare products, with product sales tied to delivery.
20-F for FY2025, filed Oct 31, 2025Telemedicine services are provided to both private sector and public sector. The Company earns telemedicine services revenue from private…View ↗
The services are rendered by the Company’s in-house doctors and external service providers who are registered and credentialed to deliver…View ↗
The Company sells prescription drugs, non-prescription drugs and healthcare products to clinics and end customers offline and online. The…View ↗
20-F/A, filed Apr 9, 2026
FY2025 revenue by reportable segment ↗$7.6M
20-F, filed Apr 9, 2026
$7.6M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Telemedicine and Other Services
Sold outright
20-F for FY2025, filed Oct 31, 2025 |
89%
FY2022: 88%
|
Telemedicine and Other Services, FY2025
$6.8M Sources
|
Sold outright |
|
Sale of Medicine and Medical Devices
Sold outright
20-F for FY2025, filed Oct 31, 2025 |
11%
FY2022: 12%
|
Sale of Medicine and Medical Devices, FY2025
$846.5K Sources
|
Sold outright |
Patients pay through the MaNaDr platform for teleconsultations; clinics and healthcare providers buy pharmaceutical products offline, while end customers can buy products online through MaNaShop/MaNaStore.
20-F for FY2025, filed Oct 31, 2025The services are rendered by the Company’s in-house doctors and external service providers who are registered and credentialed to deliver…View ↗
The Company sells prescription drugs, non-prescription drugs and healthcare products to clinics and end customers offline and online. The…View ↗
We have demonstrated our ability to monetize our large and increasingly diversified user base, and sustain our growth from diverse medical…View ↗
No. It lost $3.4M in FY2025.
20-F, filed Apr 9, 2026
−$3.5MView ↗
20-F, filed Apr 9, 2026
−$3.4MView ↗
20-F, filed Apr 9, 2026
−$4.4MView ↗
Loading...